January 29, 2025

Urticaria, Fever, Joint Pain: Beyond Standard Treatment

A 58-year-old woman presents with a 2-year history of antihistamine-resistant urticaria, accompanied by intermittent fevers and joint pain. While glucocorticoids provide temporary relief, symptoms return upon discontinuation. What's your diagnosis?

Conexiant

January 22, 2025

Phase 3 Data Evaluates New Dermatomyositis Measure

Data from a phase III trial demonstrate the sensitivity of a new composite measure in detecting treatment effects for skin and muscle disease activity in dermatomyositis.

Conexiant

January 22, 2025

Cutaneous Head and Neck Melanoma: Better Outcomes with ICIs

Explore the distinct clinicopathological features and treatment outcomes of cutaneous head and neck melanoma versus other melanoma sites.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 13, 2025

Vitiligo Treatment: ASCS vs. NB-UVB

Autologous skin cell suspension therapy demonstrates effective and durable repigmentation for stable vitiligo, showing higher repigmentation rates compared to narrow-band ultraviolet B therapy alone.

Conexiant

January 10, 2025

Remission Key to Successful Glucocorticoid Tapering

Discover how remission, hydroxychloroquine use, and gradual glucocorticoid tapering reduce flare risks in systemic lupus erythematosus.

Conexiant

January 07, 2025

Patient Insights on HRQOL in Chronic GVHD

Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains.

Conexiant

January 07, 2025

Air Pollution’s Role in Autoimmune Risks, Genetic Causal Links

Research examines genetic links between air pollution and autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.

Conexiant

January 02, 2025

Glutamatergic Drugs Reduce OCD Symptoms, Study Shows

A meta-analysis suggests that glutamatergic medications significantly reduce obsessive-compulsive disorder symptoms but calls for further research due to study limitations.

Conexiant